March 2019

Home  /  2019  /  March

EUnetHTA recently started a new Joint Assessment on a medicinal product for secondary progressive MS. To find out about participation, please read more here. Input submissions will be received through till EOB, April 28th.

Please see the below Final Project Plan of the Fourth Pharma Joint Assessment on 'sotagliflozin for adult patients with Type 1 Diabetes Mellitus who have inadequate blood glucose control using insulin or insulin analogues.' Timelines will change slightly due to the